| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.35 | 0.06 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.31 | 0.06 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.098 | 0.06 |